Insider Transactions in Q2 2025 at Adc Therapeutics Sa (ADCT)
Insider Transaction List (Q2 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 13
2025
|
Robert Azelby Director |
SELL
Payment of exercise price or tax liability
|
Direct |
12,600
-13.55%
|
$37,800
$3.58 P/Share
|
Jun 13
2025
|
Jean Pierre Bizzari Director |
SELL
Payment of exercise price or tax liability
|
Direct |
12,600
-10.54%
|
$37,800
$3.58 P/Share
|
Jun 13
2025
|
Peter Hug Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,144
-0.96%
|
$6,432
$3.58 P/Share
|
Jun 13
2025
|
Viviane Monges Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,584
-1.76%
|
$7,752
$3.58 P/Share
|
Jun 13
2025
|
Victor Sandor Director |
SELL
Payment of exercise price or tax liability
|
Direct |
12,600
-10.42%
|
$37,800
$3.58 P/Share
|
Jun 13
2025
|
Ron Squarer Director |
SELL
Payment of exercise price or tax liability
|
Direct |
15,184
-13.95%
|
$45,552
$3.58 P/Share
|
Jun 03
2025
|
Robert Azelby Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+30.07%
|
-
|
Jun 03
2025
|
Victor Sandor Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+24.86%
|
-
|
Jun 03
2025
|
Timothy Coughlin Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+50.0%
|
-
|
Jun 03
2025
|
Ron Squarer Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+26.88%
|
-
|
Jun 03
2025
|
Viviane Monges Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+21.43%
|
-
|
Jun 03
2025
|
Peter Hug Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+15.23%
|
-
|
Jun 03
2025
|
Jean Pierre Bizzari Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+25.08%
|
-
|
May 15
2025
|
Hans Peter Wild > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
9,788,944
+50.0%
|
-
|
May 15
2025
|
Thomas Pfisterer |
SELL
Other acquisition or disposition
|
Direct |
451,856
-72.21%
|
-
|
May 06
2025
|
Ameet Mallik Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
26,758
-1.69%
|
$26,758
$1.29 P/Share
|